This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Weill Medical College of Cornell University, a private research university, for whole genomic sequencing services. The contract, valued at $138,700.00, is for the Sequencing Quality Control (SeQC2) study, which involves sample processing, library construction, sequencing, and data analysis. The work will be performed by Weill Medical College and its subcontractor, Hudsonalpha Institute for...
This $4,428.00 firm-fixed-price purchase order was awarded by the Southeast Area division of a civilian federal agency to Cornell University. The contract is for DNA/RNA isolation, construction of libraries for next-generation sequencing, and bioinformatics/data analysis services. The work is to be completed by December 31, 2018. This appears to be an individual contract award, not associated with a larger contract vehicle. No set-aside designation was mentioned. Cornell University is a...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $237,188.40 and no set-aside designation. Illumina will provide a range of sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq, along with associated reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and...
This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit organization and manufacturer of sequencing and genomic analysis solutions. The contract, valued at $112,216.00, is for the purchase of Illumina's sequencing systems, reagents, and other products to support genomic research and diagnostics. The contract is a firm fixed price purchase order with no set-aside designation....
This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract has a ceiling value of $924,805.20 and a period of performance ending on March 23, 2019. The award is for the provision of high-throughput sequencing equipment and services, with no set-aside designation. Illumina has a history of supporting genomic sequencing and analysis requirements across various...
This federal contract award was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services. The $20,380 purchase order was awarded to Illumina, Inc., a for-profit manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is not designated as a set-aside. Illumina has previously held prime federal contracts and subcontracts with various agencies, including...
This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to the HudsonAlpha Institute for Biotechnology, a non-profit organization located in Huntsville, Alabama. The contract, valued at $17,671.84, is for providing genomic sequencing services and RNA kits. There is no set-aside designation for this contract. HudsonAlpha has a history of providing specialized genomic services to various federal agencies,...
This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the U.S. Department of Health and Human Services, to the HudsonAlpha Institute for Biotechnology, a non-profit research organization located in Huntsville, Alabama. The contract, valued at $15,756, is for genomic sequencing services and does not have a set-aside designation. HudsonAlpha has provided specialized genomic sequencing services to...
This is a firm fixed price delivery order awarded to Illumina, Inc. by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health. The $149,950.32 contract is for the provision of Illumina's genomic sequencing systems, reagents, and related services to support research and diagnostic applications. Illumina has a history of providing sequencing products and services to federal agencies including the NIH, CDC, USDA, and VA. The award is not...
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis products. The award, valued at $396,250.61, is for the supply of reagent chemistry kits. The contract does not have a set-aside designation. Through this award, Illumina will provide the FDA with a range of its sequencing systems, reagents, and related consumables to support genomic sequencing and analysis...
This federal contract award was issued by the Food and Drug Administration (FDA) to Weill Medical College of Cornell University, a private research university, for the sequencing of genomic DNA. The contract has a ceiling value of $268,000.00 and was awarded on May 23, 2016 with a completion date of December 30, 2016. The contract is a firm fixed-price purchase order and does not have a set-aside designation.
The contract is part of the FDA's broader "SEQUENCE GENOMIC DNA" program, which supports the agency's biomedical research and medical innovations. As a prime contractor, Weill Medical College has a strong track record of securing federal funding for its research and clinical initiatives, including a significant Indefinite Delivery Contract (IDC) with the National Cancer Institute. For this specific award, Weill Medical College subcontracted a portion of the work to the HudsonAlpha Institute for Biotechnology, a nonprofit research organization specializing in genomics and biotechnology.